Alps Advisors Inc Eq Rx, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $2,485 - $3,458	1,497 Added 0.42%	359,732 $798,000
Q2 2023 Aug 14, 2023	BUY	$1.61 - $1.96 $58,491 - $71,206	36,330 Added 11.29%	358,235 $666,000
Q1 2023 May 10, 2023	SELL	$1.8 - $2.83 $16,542 - $26,007	-9,190 Reduced 2.78%	321,905 $624,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $177,306 - $475,700	86,491 Added 35.36%	331,095 $814,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $42,065 - $268,058	-44,751 Reduced 15.47%	244,604 $1.21 Million
Q2 2022 Aug 11, 2022	BUY	$3.2 - $5.69 $925,936 - $1.65 Million	289,355 New	289,355 $1.36 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.